Moderna stock downgrade: Openheimer analyst discusses why he downgraded the stock to neutral

Sharing is Caring!

Hartaj Singh, Oppenheimer Analyst, joins Yahoo Finance to discuss downgrading Moderna earlier this month, future outlook on the stock, and questions around booster shots.

See also  Stock Indicator Creating A Top Similar To 2000?
See also  Moderna Never Had a Sample of the Virus

Views: 4

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.